Trials By City
- Aberdeen Clinical Trials
- Airway Heights Clinical Trials
- Anacortes Clinical Trials
- Auburn Clinical Trials
- Bellevue Clinical Trials
- Bellingham Clinical Trials
- Bonney Lake Clinical Trials
- Bothell Clinical Trials
- Bremerton Clinical Trials
- Centralia Clinical Trials
- Chehalis Clinical Trials
- Coupeville Clinical Trials
- Dayton Clinical Trials
- Edmonds Clinical Trials
- Ellensburg Clinical Trials
- Enumclaw Clinical Trials
- Everett Clinical Trials
- Federal Way Clinical Trials
- Gig Harbor Clinical Trials
- Granite Falls Clinical Trials
- Ilwaco Clinical Trials
- Issaquah Clinical Trials
- Kenmore Clinical Trials
- Kennewick Clinical Trials
- Kent Clinical Trials
- Kirkland Clinical Trials
- Lacey Clinical Trials
- Lakewood Clinical Trials
- Longview Clinical Trials
- Lynnwood Clinical Trials
- Marysville Clinical Trials
- Mercer Island Clinical Trials
- Mill Creek Clinical Trials
- Monroe Clinical Trials
- Moses Lake Clinical Trials
- Mount Vernon Clinical Trials
- Mountlake Terrace Clinical Trials
- Olympia Clinical Trials
- Pasco Clinical Trials
- Port Angeles Clinical Trials
- Port Orchard Clinical Trials
- Poulsbo Clinical Trials
- Pullman Clinical Trials
- Puyallup Clinical Trials
- Rainier Clinical Trials
- Redmond Clinical Trials
- Renton Clinical Trials
- Richland Clinical Trials
- Roslyn Clinical Trials
- Sammamish Clinical Trials
- Seattle Clinical Trials
- Selah Clinical Trials
- Sequim Clinical Trials
- Shelton Clinical Trials
- Silverdale Clinical Trials
- Snohomish Clinical Trials
- South Bend Clinical Trials
- Spokane Clinical Trials
- Tacoma Clinical Trials
- Toppenish Clinical Trials
- University Place Clinical Trials
- Vancouver Clinical Trials
- Vashon Clinical Trials
- Walla Walla Clinical Trials
- Wenatchee Clinical Trials
- Woodinville Clinical Trials
- Yakima Clinical Trials
- Zillah Clinical Trials
Tacoma Washington Clinical Trials
Listings Sponsored By:
The purpose of this study is to determine whether apremilast is safe and effective for treating patients with psoriatic arthritis.
Status: Recruiting Start Date: August 2013 Completion Date: January 2017
The primary objective of the study is to estimate the annualized relapse rate (ARR) over a 12-month period in patients with relapsing forms of MS who are treated with dimethyl fumarate (DMF) after suboptimal response to glatiramer acetate (GA). The secondary [more...] objectives of this study in this study population are to assess the impact of DMF over a 12-month period on patient-reported outcomes (PROs) and health economic-related outcomes and to evaluate additional clinical outcomes at Month 12.
Status: Recruiting Start Date: July 2013 Completion Date: July 2015
The purpose of this study is to compare the changes in pain and self-perceived function between two different treatments for Achilles tendinopathy: the Astym® protocol (a form of soft tissue mobilization using instruments) and a specific exercise protocol that involves [more...] strengthening the calf and Achilles tendon. Astym® (A-stim) is not an acronym, but rather stands for "A Stimulation" of the body's healing response, describing the physiologic process which occurs with Astym treatment. Astym is the trademark name of a non-invasive treatment where instruments are applied topically to locate unhealthy soft tissue, and to transfer mild to moderate pressure to the underlying soft tissue structures. The aim of Astym treatment is to eliminate scar tissue and stimulate tissue regeneration. Both the principal investigator and co-investigator have been trained and certified in administering the Astym treatment. The specific exercise protocol will involve exercises that strengthen the Achilles and calf through eccentric exercise. Eccentric exercise is a form of exercise where the benefit comes from applying a controlled lengthening stress to the muscle and tendon.
Status: Recruiting Start Date: August 2013 Completion Date: October 2015
The primary purpose of this study is to evaluate the efficacy of the study drug known as LY2875358, administered alone or in combination with a second drug named Erlotinib, in participants affected by a defined type of lung cancer (MET biomarker diagnostic positive [more...] Non-Small-Cell Lung Cancer) that experienced a disease progression during the most recent treatment with Erlotinib.
Status: Recruiting Start Date: August 2013 Completion Date: November 2014
The purpose of this signal seeking study is to determine whether treatment with MEK162 demonstrates sufficient efficacy in select pathway-activated solid tumors and/or hematologic malignancies to warrant further study
Status: Recruiting Start Date: September 2013 Completion Date: April 2017
The aim of this study is to evaluate the efficacy of the candidate Clostridium difficile (C. difficile) vaccine to prevent primary symptomatic C. difficile infection (CDI) in subjects a risk for CDI where there is a substantial unmet medical need. [more...] Primary objective: - To assess the efficacy of the C. difficile vaccine in preventing the onset of symptomatic primary CDI confirmed by polymerase chain reaction (PCR) in adult subjects aged ≥ 50 years who are at risk for CDI and have received at least 1 injection. Secondary Objectives: Efficacy: - To assess prevention of symptomatic PCR-confirmed primary CDI cases after 3 injections administered at 0, 7, and 30 days - To assess prevention of symptomatic PCR-confirmed primary CDI cases after completion of at least 2 injections. Immunogenicity: - To describe the immunogenicity to toxin A and toxin B in the subset of subjects at specific time points. Safety: - To describe the safety profile of all subjects who receive at least 1 injection.
Status: Recruiting Start Date: July 2013 Completion Date: December 2017
The purpose of this study is to investigate the long-term safety and any side effects of baricitinib in participants who have completed a previous baricitinib rheumatoid arthritis study. The study provides for 2 years of additional treatment with baricitinib, [more...] but may be extended to allow for continued treatment for up to 5 years after evaluation of the safety profile of baricitinib.
Status: Recruiting Start Date: June 2013 Completion Date: June 2020
This randomized, multicenter, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of lebrikizumab in patients with idiopathic pulmonary fibrosis. Patients will be randomized to receive either lebrikizumab or placebo subcutaneously every 4 weeks.
Status: Recruiting Start Date: August 2013 Completion Date: June 2016
The overall objective of this study is to assess the efficacy and safety of treatment with PT003 (GFF MDI), PT005 (FF MDI), PT001 (GP MDI), and open-label tiotropium bromide inhalation powder compared with each other and Placebo MDI over 24 weeks in subjects with [more...] moderate to very severe COPD.
Status: Recruiting Start Date: May 2013 Completion Date:
This study will evaluate the safety and efficacy of ABT-719 in patients undergoing high risk major surgery.
Status: Recruiting Start Date: May 2013 Completion Date: October 2014
Primary Objective: To evaluate the efficacy of different doses and regimens of dupilumab in patients with moderate to severe, uncontrolled asthma Secondary Objective: To evaluate different doses and regimens of dupilumab in patients with [more...] moderate to severe uncontrolled asthma, with regard to: - Safety and tolerability - Dupilumab systemic exposure and anti-drug antibodies
Status: Recruiting Start Date: June 2013 Completion Date: May 2015
To compare the treatment effect of PEGPH20 combined with nab-paclitaxel and gemcitabine (PAG) to nab-paclitaxel and gemcitabine (AG) in subjects with Stage IV pancreatic cancer. Phase 2 (safety and treatment effect), 124 subjects, 1:1 ratio, PAG:AG, preceded by 8 [more...] subject Run-In phase (safety and tolerability).
Status: Recruiting Start Date: April 2013 Completion Date: September 2015
The purpose of this study is to determine if ibuprofen use after electrocautery tonsillectomy increases the post-tonsillectomy hemorrhage rate. Hypothesis: Use of ibuprofen does not increase the post-tonsillectomy hemorrhage rate. Primary outcome: Rate of tonsillar hemorrhage following adult [more...] tonsillectomy in those receiving narcotic pain medications plus ibuprofen compared to those receiving narcotics alone. Secondary outcome: Determine whether ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), decreases post tonsillectomy pain, narcotic pain medication use, or cost of pain management.
Status: Recruiting Start Date: April 2013 Completion Date: May 2016
The purpose of this signal seeking study is to determine whether treatment with BKM120 demonstrates sufficient efficacy in select pathway-activated solid tumors and/or hematologic malignancies to warrant further study.
Status: Recruiting Start Date: March 2013 Completion Date: February 2017
The primary purpose of this study is to evaluate the safety for 2 different rivaroxaban treatment strategies and one Vitamin K Antagonist (VKA) treatment strategy utilizing various combinations of dual antiplatelet therapy (DAPT) or low-dose aspirin (ASA) or clopidogrel [more...] (or prasugrel or ticagrelor).
Status: Recruiting Start Date: May 2013 Completion Date: December 2015
This is an open-label, multicenter, sequential dose-escalation, and expansion study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GS-5745 alone and in combination with chemotherapy.
Status: Recruiting Start Date: April 2013 Completion Date: January 2015
This is a study to evaluate the efficacy, safety, tolerability, and pharmacodynamics of GS-9973 and idelalisib. Participants will be enrolled who have one of the following hematological tumor types: chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), mantle cell lymphoma [more...] (MCL), diffuse large B-cell lymphoma (DLBCL), or non-FL indolent non-Hodgkin lymphomas (iNHL; including lymphoplasmacytoid lymphoma/Waldenström macroglobulinemia [LPL/WM], small lymphocytic lymphoma [SLL], or marginal zone lymphoma [MZL]).
Status: Recruiting Start Date: April 2013 Completion Date: April 2016
The main purpose of the study is to evaluate the efficacy and safety of the study drug known as prasugrel for the reduction of Vaso-Occlusive Crisis events in pediatric participants with sickle cell disease. The study will also investigate reduction in daily pain in [more...] children who have sickle cell disease.
Status: Recruiting Start Date: April 2013 Completion Date: May 2016
This randomized phase III trial studies armodafinil to see how well it works in reducing cancer-related fatigue in patients with glioblastoma multiforme. Armodafinil may help relieve fatigue in patients with glioblastoma multiforme.
Status: Recruiting Start Date: June 2013 Completion Date:
This study will evaluate the safety and efficacy of ABT-719 in preventing acute kidney injury in patients undergoing high risk cardiac surgery.
Status: Recruiting Start Date: July 2012 Completion Date: March 2014
Clinical trials allow volunteers access to medical treatment options before they are available to the general public. Participants often receive the best healthcare available for their condition.
Risks are a reality, however, and may include more frequent doctor visits, health risks (possibly life-threatening), and/or the treatment being ineffective. Trials are federally regulated with strict guidelines to protect participants.
Tacoma Washington Clinical Trials Information presented on ClinicalTrialsSearch.org is not intended to be a substitute for qualified medical advice visit or treatment with a real physician. We are not physicians. Always consult with a medical doctor (MD). ClinicalTrialsSearch.org is a website dedicated to listing clinical research studies in human subjects, including those specifically related to Tacoma Washington. Clinical research trials and medical trials take place in hundreds of cities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectiveness of new treatments and drugs. The purpose of the studies is to answer specific human health questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions. Clinical trials allow volunteers access to medical treatment options before they are available to the general public. Many times the participants receive treatment for free, and sometimes they are paid for their time. Participants often receive the best healthcare available possible for their condition. Risks are a reality, however, and may include more frequent doctor visits, health risks (possibly life-threatening), and/or the treatment being ineffective. U.S. - based Tacoma Washington studies are federally regulated with strict guidelines to protect patients.
There are a number of clinical trials underway to find effective treatments for diabetes, including new drugs, surgery and even transplantation.
There are several current and ongoing trials of interventions for major depressive disorder, which is characterized by a disabling combination of symptoms causing severe disruption to the sufferer's ability to carry out routine functions and tasks of daily life.
Constipation is a illness where the bowels cannot move waste material out of the body in a normal manner. There are various clinical trials recruiting participants to study the effectiveness of various treatments.